Skip to main content

Table 1 Characteristics of included pneumococcal publications

From: Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review

Author

Year published

Country

Type

Setting

Age Categories

Linkage

Serotype

Number colonized (%)

Number infected (%)

Case-Fatality Ratio

McCrae T

1916

Canada

Respiratory

Community

      

Miller JL

1918

United States

Respiratory

Military

    

346

0.325

Schroder MC

1930

United States

Respiratory

School

Children

 

5

 

150

 

Smillie WG

1936

United States

Respiratory

Hospital

  

2

21

17

0.471

Tilghman RC

1936

United States

Respiratory

Community

Toddler, Children, Young Adult, Adult, Older Adult

 

Variety

   

Gilman BB

1938

United States

Multiple

Community

 

Neufeld

1

 

35 (7.0%)

0.114

Smillie WG

1938

United States

Respiratory

Hospital

  

1

(10.0%)

110

 

Mackenzie GM

1940

United States

Respiratory

Community

 

Neufeld

1

43 (18.0%)

4 (1.6%)

 

Hodges RG*

1946

United States

Respiratory

Military

 

Neufeld

Variety

 

1644

0

Hodges RG*

1946

United States

Respiratory

Military

 

Neufeld

Variety

 

1644

0

Hodges RG*

1946

United States

Respiratory

Military

 

Neufeld

Variety

 

1644

0

Hodges RG*

1946

United States

Respiratory

Military

 

Neufeld

Variety

 

1644

0

Hodges RG*

1946

United States

Respiratory

Military

 

Neufeld

Variety

 

1644

0

DeMaria A

1980

United States

Respiratory

Community

 

Quelleng

1

10 (10%)

39

 

Shayegani M

1982

United States

Conjunctivis

Community

  

Nontypeable

 

1567

0

Shayegani M

1983

United States

Conjunctivis

Military

  

Nontypeable

 

80

0

Fenton PA

1983

United Kingdom

Respiratory

Community

  

1

   

Shayegani M

1984

United States

Conjunctivis

Community

Adult, Older Adult

 

Nontypeable

 

1189

0

Davies AJ

1984

United Kingdom

Respiratory

Hospital

 

Immunoelectrophoresis

9

 

4

 

Berk SL

1985

United States

Respiratory

Hospital

Older Adult

Quelleng

8

0 (0%)

4 (18.0%)

0.500

Collingham KE

1985

United States

Respiratory

Community

Older Adult

 

12

 

2

0.500

Mehtar S

1986

United Kingdom

Respiratory

Hospital

Toddler

 

6

 

3

0.333

Davies AJ

1987

United Kingdom

Respiratory

Hospital

Older Adult

Quelleng

3

 

8

0.250

Gould FK

1987

United Kingdom

Respiratory

Hospital

Older Adult

 

23

 

6

 

Moore EP

1988

United Kingdom

Respiratory

Hospital

Older Adult

 

23

 

4

0.250

CDC*

1989

United States

Respiratory

Jail

Young Adult, Adult

Quelleng

12F

11 (7.0%)

17 (0.5%)

0.043

Rauch AM

1990

United States

Respiratory

Daycare

Toddler

 

14

10 (9.3%)

2 (2.4%)

0

Bain M

1990

United Kingdom

Respiratory

Hospital

Older Adult

Quelleng

4

 

4

 

Mercat A

1991

France

Respiratory

Community

Young Adult, Adult, Older Adult

Quelleng

1

1 (2.0%)

39

0.040

Cartmill TDI

1992

United Kingdom

Respiratory

Hospital

Older Adult

 

6

1

4

0.250

Dawson S

1992

United Kingdom

Respiratory

Hospital

Older Adult

 

6

1

5

 

PHLS

1992

United Kingdom

Respiratory

Hospital

  

9

 

7

0.143

Quick RE

1993

United States

Respiratory

Long-term care facility

Older Adult

Quelleng

9 V

2 (3.0%)

7 (7.4%)

0.710

Gratten M

1993

Australia

Respiratory

Community

Young Adult, Adult, Older Adult

Antisera

1

13 (17.3%)

18

 

Denton M

1993

United Kingdom

Respiratory

Hospital

Older Adult

 

14

 

8

0.125

Hoge CW*

1994

United States

Respiratory

Jail

Young Adult, Adult

Quelleng

12F

11 (7.0%)

46 (0.5%)

0.043

Cherian T

1994

United States

Respiratory

Daycare

Toddler

Ribotyping

12F

6 (100%)

4 (66.7%)

0

Millar MR

1994

United Kingdom

Respiratory

Hospital

Older Adult

 

9

0 (0%)

10 (5.7%)

 

Mandigers CMPW

1994

Netherlands

Respiratory

Hospital

Older Adult

Quelleng

9

 

18

0.556

Nims L

1994

United States

Respiratory

Daycare

Toddler

PCR

19

3

14

0.500

Raymond J

1995

France

Respiratory

Hospital

Toddler

RAPD

23F

 

2

 

Ertugrul N

1997

United States

Conjunctivis

Military

 

PFGE, PCR

Nontypeable

 

561

0

Marton A

1997

Hungary

Otitis Media

Hospital

Toddler

  

0

6

 

Marton A

1997

Hungary

Otitis Media

Hospital

Toddler

   

3

 

Gillespie SH

1997

United Kingdom

Respiratory

Hospital

Older Adult

RFLP

9

3

9

0.444

CDC*

1997

United States

Respiratory

Long-term care facility

Older Adult

PCR

14

 

10 (14.9%)

0.200

CDC*

1997

United States

Respiratory

Long-term care facility

Older Adult

PFGE

23F

17 (23.0%)

11 (13.0%)

0.270

CDC

1997

United States

Respiratory

Long-term care facility

Older Adult

PCR

4

 

14 (11.7%)

0.290

Musher DM

1997

United States

Respiratory

Military

Young Adult

 

1

 

128 (3.2%)

 

Musher DM

1997

United States

Respiratory

Military

Young Adult

 

7F / 8

44 (28.4%)

14 (6.4%)

 

Fiore AE*

1998

United States

Respiratory

Long-term care facility

Older Adult

PCR

14

 

10 (14.9%)

0.200

Nuorti JP*

1998

United States

Respiratory

Long-term care facility

Older Adult

PFGE

23F

17 (23.0%)

11 (13.0%)

0.27

Sheppard DC

1998

United States

Respiratory

Long-term care facility

Older Adult

PFGE

14

0 (0%)

15 (12.5%)

 

Razzaq N

1998

United Kingdom

Respiratory

Community

Toddler, Older Adult

 

12F

 

2

 

Craig AS

1999

United States

Respiratory

Daycare

Toddler

PFGE

14

15 (19%)

3 (3.4%)

0

de Galan BE

1999

Netherlands

Respiratory

Hospital

Older Adult

Quelleng, RFEL

15

 

36

0.297

Kellner JD

1999

Canada

Respiratory

Community

Adult, Older Adult

PFGE

  

6

0.167

Leggiadro RJ

1999

United States

Respiratory

Long-term care facility

Older Adult

  

4

3

 

Gleich S

2000

United States

Respiratory

Long-term care facility

Older Adult

PFGE

4

 

11 (5.5%)

 

Dagan R

2000

Israel

Respiratory

Community

 

Ribotyping, PCR

1

31 (4.8%)

5

 

Nakashima T

2001

Japan

Otitis Media

Daycare

Children

Antisera, RAPD

19, 23, 6

 

7

 

CDC*

2001

United States

Respiratory

Long-term care facility

Older Adult

PFGE

14

 

9

0.444

Weiss K

2001

Canada

Respiratory

Hospital

Older Adult

PFGE

23F

 

23

0.087

CDC

2002

United States

Conjunctivis

School

Children, Young Adult, Adult

PFGE

Nontypeable

 

144

 

Melamed R

2002

Israel

Respiratory

Hospital

Toddler

RAPD

5

0

3

 

Martin M

2003

United States

Conjunctivis

Community

Young Adult

PFGE, MLST

Nontypeable

20 (8.1%)

698 (13.8%)

 

Tan CG*

2003

United States

Respiratory

Long-term care facility

Older Adult

PFGE

14

 

9

0.444

Crum NF

2003

United States

Respiratory

Military

Young Adult

Quelleng, Latex Agglutination

9 V / 4

13 (11.0%)

52 (1.5%)

0

Subramanian D

2003

United Kingdom

Respiratory

Hospital

 

PFGE

9 V

3 (5.5%)

9

 

Sanchez JL

2003

United States

Respiratory

Military

Young Adult

PCR

3, 6, 9, 14, 20, 22, 23

30 (13.6%)

30 (12.1%)

 

Crum NF

2004

United States

Conjunctivis

Military

Young Adult, Adult

MLST

Nontypeable

15 (9.9%)

80 (2.3%)

0

Banerjee A

2005

India

Respiratory

Military

 

RAPD

   

0

CDC

2005

United States

Respiratory

Hospital

Adult

PFGE

23F, 3

6 (9.0%)

7

0.290

CDC*

2005

United States

Respiratory

Community

Toddler, Children, Young Adult, Adult, Older Adult

PFGE, MLST, MLBT

12F

46 (2.4%)

14 (0.1%)

 

Birtles A

2005

United Kingdom

Respiratory

Community

Adult

MLST

8

 

2

1

Buck JM

2006

United States

Conjunctivis

Community

Toddler, Children, Young Adult, Adult, Older Adult

PFGE, MLST

Nontypeable

 

735

0

Hennick M

2006

Canada

Conjunctivis

Community

Toddler, Children, Young Adult, Adult, Older Adult

AFLP

Nontypeable

 

47

 

Hansmann Y

2006

France

Respiratory

Long-term care facility

Older Adult

Antisera, Urine

4

1 (1.2%)

11 (11.7%)

0.273

Singh PMP

2006

India

Respiratory

Military

Young Adult

   

316

0

Cashman P

2007

Australia

Respiratory

School

Children

 

1

 

25

 

Sheppard CL

2008

United Kingdom

Respiratory

Community

Children, Young Adult, Adult

PCR, MLST

1

 

11

0.182

Romney MG

2008

Canada

Respiratory

Community

Toddler, Children, Young Adult, Adult, Older Adult

Latex Agglutination

5

 

137

0.080

Zegans ME

2009

United States

Conjunctivis

Community

Young Adult

PFGE, MLST

Nontypeable

20 (8.1%)

698 (13.8%)

 

Vainio A

2009

Finland

Respiratory

Military

 

MLST

7F

9 (20.9%)

5 (12.0%)

0

Gupta A

2009

United Kingdom

Respiratory

School

Children

ELISA, Urine

1

1 (1.2%)

5

 

Mehiri-Zghal E

2010

Tunisia

Respiratory

Jail

 

PFGE

1

9 (45.0%)

150 (3.8%)

 

Balicer RD

2010

Israel

Respiratory

Military

Young Adult

PFGE, MLST

5

35 (24.1%)

34

0

Pichon B

2010

United Kingdom

Respiratory

Community

 

MLST

5

 

8

 

Dawood FS

2011

United States

Respiratory

Military

Young Adult

Quelleng

7F

16 (4.3%)

74 (0.3%)

0.027

Vanderkooi OG

2011

Canada

Respiratory

Community

Children, Young Adult, Adult, Older Adult

Quelleng, MLST

5, 8

 

207

 

Skoczynska A

2012

Poland

Respiratory

Hospital

Older Adult

PFGE, MLST

14

 

6

 

Fleming-Dutra K

2012

United States

Respiratory

Hospital

Children, Young Adult

PCR, MLST

15A

6

11

 

Guillet M

2012

France

Surgical Site

Hospital

  

3

1

4

 

Zulz T*

2013

United States

Respiratory

Community

Toddler, Children, Young Adult, Adult, Older Adult

PFGE, MLST, MLBT

12F

46 (2.4%)

14 (0.1%)

 

CDC

2013

United States

Respiratory

Long-term care facility

Adult, Older Adult

 

3

 

7 (50.0%)

0.430

Kuroki T

2014

Japan

Respiratory

Hospital

Older Adult

PFGE, MLST

3

 

16 (83.9%)

0.063

Ben-David D

2014

Israel

Respiratory

Hospital

Young Adult, Older Adult

PFGE, MLST

19F, 23F

21 (20.2%)

66

 

Schillberg E

2014

Canada

Respiratory

Community

Children, Young Adult, Adult, Older Adult

Quelleng, PFGE, MLST, MLVA

12F

 

32

 

Suryam V

2015

India

Respiratory

Military

    

52

0

Thomas HL

2015

United Kingdom

Respiratory

Long-term care facility

Older Adult

Urinary, MLST

8

 

15 (65.0%)

0.133

Kunwar R

2015

India

Respiratory

Military

Young Adult

   

58 (1.1%)

0

Sheppard CL

2016

United Kingdom

Respiratory

Hospital

Older Adult

Urinary

6C

 

13

0.231

Ewing J

2017

United Kingdom

Respiratory

Workplace

Young Adult, Adult, Older Adult

WGS, MLST

4

 

25

0

Jauneikaite E

2017

United Kingdom

Respiratory

Hospital

Older Adult

WGS, MLST

9 V

 

4

 
  1. PCR polymerase chain reaction, RAPD random amplified polymorphic DNA, PFGE pulse-field gel electrophoresis, RFLP restriction fragment length polymorphism, RFEL restriction fragment end labeling, MLST multilocus sequence type, AFLP amplified fragment length polymorphism, ELISA enzyme-linked immunosorbent assay, MLBT multilocus boxB sequence typing, MLVA multiple loci variable-number tandem repeat analysis, WGS whole genome sequencing
  2. Age categories are defined as follows; toddler (0–2 years old), children (3–17), young adult (18–25), adult (26–49), and older adult (50+)
  3. Settings falling outside the other indicated categories were considered as “Community” settings. These included transmission among families, homeless shelter outbreaks, outbreaks in socially disadvantaged groups, and transmission occurring generally within geographical regions
  4. *Outbreaks that were described in multiple publications. See supplement data set containing unique identifiers for each outbreak report